BackItem 9 Labs Overview

Item 9 Labs Other Current Liabilities

Latest other current liabilities for INLB: $18M.

Get informed when a big investor buys or sells

+ Follow
Other Current Liabilities
$17.62M
↑ 244.34% YoYΔ $12.50M vs prior year quarter

Peer trimmed avg / median

Loading

Item 9 Labs Other Current Liabilities History

Loading

Item 9 Labs vs. peers: Other Current Liabilities Comparison

Loading

Item 9 Labs Other Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Item 9 Labs (INLB) FAQ

As of the most recent data (June 2023), INLB shows a other current liabilities of $18M. That compares with $5.1M in the prior-year period — up 244.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, INLB's other current liabilities is now $18M (was $5.1M) — a 244.3% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Item 9 Labs is outperforming or lagging.

Tracking INLB's other current liabilities over time shows whether Item 9 Labs is scaling, shrinking, or reshaping that part of the business. The current reading is $18M That compares with $5.1M in the prior-year period — up 244.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current liabilities page, Stockcircle has Item 9 Labs's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current liabilities (currently $18M) with ownership activity and broader fundamentals.